• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL2200061 盐酸恩沙替尼胶囊 Ensartinib Hydrochloride Capsule Chemical Drugs(2.4) New Drug Application 2022-01-28 Betta Pharmaceuticals Co Ltd view
CXHL2200060 盐酸恩沙替尼胶囊 Ensartinib Hydrochloride Capsule Chemical Drugs(2.4) New Drug Application 2022-01-28 Betta Pharmaceuticals Co Ltd view
CYHB2101570 盐酸恩沙替尼胶囊 Ensartinib Hydrochloride Capsule Chemical Drugs(1) Supplementary Application 2021-07-13 Betta Pharmaceuticals Co Ltd view
CXHS2101028 盐酸恩沙替尼胶囊 Ensartinib Hydrochloride Capsule Chemical Drugs(2.4) New Drug Application 2021-07-13 Betta Pharmaceuticals Co Ltd view
CYHB2101569 盐酸恩沙替尼胶囊 Ensartinib Hydrochloride Capsule Chemical Drugs(1) Supplementary Application 2021-07-13 Betta Pharmaceuticals Co Ltd view
CXHS2101029 盐酸恩沙替尼胶囊 Ensartinib Hydrochloride Capsule Chemical Drugs(2.4) New Drug Application 2021-07-13 Betta Pharmaceuticals Co Ltd view